Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
31,360,806
-
Share change
-
+8,088,250
-
Total reported value
-
$1,155,631,753
-
Put/Call ratio
-
84%
-
Price per share
-
$36.85
-
Number of holders
-
117
-
Value change
-
+$338,516,699
-
Number of buys
-
85
-
Number of sells
-
44
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q1 2017
As of 31 Mar 2017,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,360,806 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, WHITE SQUARE CAPITAL LLP, ORBIMED ADVISORS LLC, Redmile Group, LLC, CITADEL ADVISORS LLC, and venBio Select Advisor LLC.
This page lists
117
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.